CCEL
CryoCell International Inc
3.50$
-19.8%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 83.2% | 53.1% | 46.1% | 53.3% | 69.7% | 35.9% | 40.2% | 26.0% | 14.8% | 15.4% | 19.4% | 19.0% | |
| 32.1% | 21.3% | 17.9% | 26.3% | 14.2% | 15.3% | 22.4% | 13.6% | 2.6% | 0.7% | 0.9% | 0.5% | |
| 33.1% | 24.4% | 21.1% | 28.1% | 16.3% | 17.4% | 22.6% | 13.7% | 2.7% | 1.6% | 5.4% | 5.3% | |
| 39.9% | 15.7% | 20.7% | 21.4% | 13.8% | 14.2% | 13.7% | 8.7% | 9.3% | 10.7% | 11.3% | 11.1% | |
| 9.0% | 2.4% | 1.8% | 1.3% | 37.8% | 2.5% | 2.0% | 1.5% | 1.3% | 1.3% | 1.0% | 0.7% | |
| 9.3% | 4.5% | 5.0% | 3.7% | 3.5% | 4.3% | 3.6% | 6.8% | 21.9% | – | – | – | |
| – | 9.1% | 0.0% | 0.0% | 4.6% | 4.5% | 4.2% | 3.2% | 3.0% | 3.2% | 3.0% | 3.1% | |
| 0.3% | 2.6% | 1.3% | 0.9% | 3.2% | 2.9% | 3.3% | 26.7% | 23.4% | 1.6% | 1.4% | 1.4% | |
| 205.1% | 125.5% | 178.9% | 152.3% | 121.0% | 116.2% | 105.8% | 93.1% | 102.3% | 118.0% | 120.4% | 130.1% | |
| 89.4% | 53.5% | 67.1% | 58.3% | 36.4% | 36.0% | 35.5% | 34.7% | 30.0% | 34.1% | 33.4% | 32.1% | |
| – | 1.6% | 10.2% | 8.4% | 7.3% | 7.2% | 7.3% | 3.6% | 4.2% | 2.6% | 6.4% | 4.7% | |
| 9.7% | 6.8% | 7.6% | 8.1% | 3.0% | 3.2% | 2.1% | 2.5% | 2.5% | 5.2% | 2.9% | 4.7% | |
| 22.5% | 4.5% | 40.0% | 22.1% | 23.2% | 13.7% | 6.1% | – | 13.2% | 13.8% | 12.8% | 13.2% | |
| -105.1% | -25.5% | -78.9% | -52.3% | -21.0% | -16.2% | -5.8% | 6.9% | -2.3% | -18.0% | -20.4% | -30.1% | |
| -328.9% | -130.6% | -137.1% | -102.4% | -59.8% | -52.3% | -40.7% | -27.6% | -33.3% | -50.9% | -50.7% | -62.3% | |
| 102.1% | 50.2% | 41.5% | 32.0% | 17.6% | 19.6% | 17.6% | 13.8% | 13.1% | 13.6% | 12.7% | 13.1% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.